[Jang R01AG058560 transfer] Role of BubR1 as a juvenile protective factor in hippocampal aging
【Jang R01AG058560转】BubR1作为幼年保护因子在海马衰老中的作用
基本信息
- 批准号:10469911
- 负责人:
- 金额:$ 34.54万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2021
- 资助国家:美国
- 起止时间:2021-09-01 至 2024-12-31
- 项目状态:已结题
- 来源:
- 关键词:AdolescentAdultAffectAgeAge-associated memory impairmentAgingAnxietyBUB1 geneBehaviorBehavioralBirthBrainCellsChildhoodClinicalCognitive agingCognitive deficitsDataDevelopmentDiseaseElectron MicroscopyElectrophysiology (science)ElementsEmbryoEtiologyExhibitsFunctional disorderGenerationsGeneticGoalsGrowthHippocampus (Brain)HumanImpaired cognitionImpairmentInterventionKnowledgeLifeMediatingMemoryMental DepressionMental RetardationMicrocephalyMitoticMitotic CheckpointMolecularMolecular TargetMusMutant Strains MiceMutationNeuronal PlasticityNeuronsPathologyPathway interactionsPatternPhosphotransferasesPlayPrevalenceProcessPublic HealthPublishingRegenerative MedicineRegulationRoleSynaptic plasticityTestingTherapeutic InterventionWNT Signaling PathwayWorkage relatedage related cognitive disorderage related neurodegenerationagedaging brainaging hippocampusbasebrain sizecognitive disabilitycognitive functionconfocal imagingdesignimprovedinhibitorinsightknock-downmouse geneticsnerve stem cellneurogenesisnew therapeutic targetnoveloverexpressionpostnatalpostnatal developmentpreventprotective factorssmall hairpin RNAtherapeutically effective
项目摘要
PROJECT SUMMARY
Aging is the most significant negative regulator of hippocampal neurogenesis, contributing to impairments in
synaptic plasticity and cognitive function. The main goal of this application is to identify juvenile protective
factors (JPFs) that are capable of maintaining neurogenesis and cognitive function in aged mice so that
effective therapeutic strategies for age-related cognitive disorders can be realized. Towards identifying novel
JPFs, we have recently provided first evidence that the mitotic checkpoint kinase BubR1 is required for
maintaining proper early brain development and hippocampal function later in life. Specifically, BubR1 level is
particularly high during early development and then declines to an adult level, followed by further decline
during the natural aging process. Given that neurogenesis is robust in childhood, but undergoes a progressive
decline with aging, such expression pattern of BubR1 correlates with age-dependent declines in neurogenesis.
However, whether sustained BubR1 levels have a protective role in the aged brain, and thus suggest a novel
JPF that maintains proper neurogenesis and related hippocampal function in aged mice, remains unknown.
Therefore, the main objective of this application is to resolve whether sustained high level of BubR1 in aged
brain prevents age-related hippocampal dysfunction. To support this idea, our preliminary data demonstrate
that BubR1 insufficiency accelerates age-dependent impairments in hippocampal neurogenesis. Importantly,
while a high level of BubR1 itself does not have any detrimental effects in young mice, it promotes
neurogenesis in aged mice. Based on these findings, our central hypothesis is that reduced BubR1 levels with
age contribute to age-dependent declines in hippocampal function, and that sustained high levels of BubR1
promote neurogenesis and improve synaptic plasticity and cognitive function in aged mice. Utilizing multiple
approaches including mouse genetics, confocal imaging, electrophysiology, and behavior analysis, Aim 1 will
determine a key downstream molecular pathway of BubR1 in regulating neurogenesis. Given the well-
established role of Wnt signaling in neurogenesis and aging, we will explore the involvement of the Wnt
signaling pathway in neurogenesis in both BubR1 insufficient and aged mice. Subsequently, Aim 2 will test
whether a sustained high level of BubR1 can restore hippocampal neurogenesis in aged mice. Lastly, Aim 3
will determine if a sustained high level of BubR1 improves synaptic plasticity and cognitive function in aged
mice in a neurogenesis-dependent manner. In summary, our findings will not only reveal the etiology of age-
related cognitive disorders, but also provide a framework by which therapeutic interventions may target
neurogenic declines during normal brain aging. Considering the prevalence of age-associated cognitive
deficits, determining the mechanistic elements improving hippocampal function will hold significant implications
for the fields of cognitive aging, neurogenesis, neural plasticity, regenerative medicine, and public health.
项目摘要
衰老是海马神经发生的最重要的负调节因子,导致海马神经元的损伤。
突触可塑性和认知功能。这项申请的主要目标是确定青少年保护
因子(JPF)能够维持老年小鼠的神经发生和认知功能,
可以实现与年龄相关的认知障碍的有效治疗策略。小说识别
JPFs,我们最近提供了第一个证据,证明有丝分裂检查点激酶BubR 1是
维持适当的早期大脑发育和海马功能在以后的生活。具体而言,BubR 1水平是
在早期发育期间特别高,然后下降到成年水平,随后进一步下降
在自然老化过程中。鉴于神经发生在儿童时期是强大的,但经历了一个渐进的过程,
随着年龄的增长而下降,这种BubR 1的表达模式与神经发生的年龄依赖性下降相关。
然而,持续的BubR 1水平是否在老年大脑中具有保护作用,从而提出了一种新的
JPF在老年小鼠中维持适当的神经发生和相关的海马功能仍然未知。
因此,本申请的主要目的是解决老年人中是否存在持续高水平的BubR 1,
大脑可以防止年龄相关的海马功能障碍。为了支持这一观点,我们的初步数据表明,
BubR 1不足加速了海马神经发生中的年龄依赖性损伤。重要的是,
虽然高水平的BubR 1本身对年轻小鼠没有任何不利影响,但它促进了小鼠的生长。
老年小鼠的神经发生。基于这些发现,我们的中心假设是,BubR 1水平降低,
年龄导致海马功能的年龄依赖性下降,
促进老年小鼠的神经发生并改善突触可塑性和认知功能。利用多个
包括小鼠遗传学,共聚焦成像,电生理学和行为分析,目标1将
确定BubR 1在调节神经发生中的关键下游分子通路。因为井-
Wnt信号在神经发生和衰老中的作用,我们将探讨Wnt信号的参与。
信号通路在BubR 1不足和老年小鼠的神经发生中的作用。随后,Aim 2将测试
持续高水平的BubR 1是否可以恢复老年小鼠海马神经发生。最后,目标3
将确定持续高水平的BubR 1是否能改善老年人的突触可塑性和认知功能。
以神经发生依赖的方式。总之,我们的研究结果不仅揭示了年龄的病因,
相关的认知障碍,但也提供了一个框架,治疗干预措施可以针对
在正常的大脑老化过程中神经原性衰退。考虑到与年龄相关的认知障碍的流行,
缺陷,确定改善海马功能的机制要素将具有重要意义
认知老化,神经发生,神经可塑性,再生医学和公共卫生领域。
项目成果
期刊论文数量(13)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
The selective cyclooxygenase-2 inhibitor NS398 ameliorates cisplatin-induced impairments in mitochondrial and cognitive function.
- DOI:10.3389/fnmol.2023.1295991
- 发表时间:2023
- 期刊:
- 影响因子:4.8
- 作者:Rashid, Mohammad Abdur;Tang, Jason J.;Yoo, Ki-Hyun;Corujo-Ramirez, Ana;Oliveros, Alfredo;Kim, Sang Hoon;Ullah, Faheem;Altawell, Raad;Hawse, John R.;Cole, Peter D.;Jang, Mi-Hyeon
- 通讯作者:Jang, Mi-Hyeon
New Roles for Old Glue: Astrocyte Function in Synaptic Plasticity and Neurological Disorders.
- DOI:10.5213/inj.1836214.107
- 发表时间:2018-10
- 期刊:
- 影响因子:2.3
- 作者:Hussaini SMQ;Jang MH
- 通讯作者:Jang MH
Early stem cell aging in the mature brain.
- DOI:10.1016/j.stem.2021.03.018
- 发表时间:2021-05-06
- 期刊:
- 影响因子:23.9
- 作者:Ibrayeva A;Bay M;Pu E;Jörg DJ;Peng L;Jun H;Zhang N;Aaron D;Lin C;Resler G;Hidalgo A;Jang MH;Simons BD;Bonaguidi MA
- 通讯作者:Bonaguidi MA
Hippocampal regenerative medicine: neurogenic implications for addiction and mental disorders.
- DOI:10.1038/s12276-021-00587-x
- 发表时间:2021-03
- 期刊:
- 影响因子:12.8
- 作者:Peyton L;Oliveros A;Choi DS;Jang MH
- 通讯作者:Jang MH
Nicotinamide Mononucleotide Prevents Cisplatin-Induced Cognitive Impairments.
- DOI:10.1158/0008-5472.can-20-3290
- 发表时间:2021-07-01
- 期刊:
- 影响因子:11.2
- 作者:Yoo KH;Tang JJ;Rashid MA;Cho CH;Corujo-Ramirez A;Choi J;Bae MG;Brogren D;Hawse JR;Hou X;Weroha SJ;Oliveros A;Kirkeby LA;Baur JA;Jang MH
- 通讯作者:Jang MH
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Mi-Hyeon Jang其他文献
Mi-Hyeon Jang的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Mi-Hyeon Jang', 18)}}的其他基金
PQ#12; Targeting Nampt-mediated NAD+ metabolism in chemobrain
质子Q
- 批准号:
10117840 - 财政年份:2019
- 资助金额:
$ 34.54万 - 项目类别:
PQ#12; Targeting Nampt-mediated NAD+ metabolism in chemobrain
质子Q
- 批准号:
10378837 - 财政年份:2019
- 资助金额:
$ 34.54万 - 项目类别:
PQ#12; Targeting Nampt-mediated NAD+ metabolism in chemobrain
质子Q
- 批准号:
10688638 - 财政年份:2019
- 资助金额:
$ 34.54万 - 项目类别:
PQ#12; Targeting Nampt-mediated NAD+ metabolism in chemobrain
质子Q
- 批准号:
10759020 - 财政年份:2019
- 资助金额:
$ 34.54万 - 项目类别:
PQ#12; Targeting Nampt-mediated NAD+ metabolism in chemobrain
质子Q
- 批准号:
10470574 - 财政年份:2019
- 资助金额:
$ 34.54万 - 项目类别:
PQ#12; Targeting Nampt-mediated NAD+ metabolism in chemobrain
质子Q
- 批准号:
10459278 - 财政年份:2019
- 资助金额:
$ 34.54万 - 项目类别:
PQ#12; Targeting Nampt-mediated NAD+ metabolism in chemobrain
质子Q
- 批准号:
10206070 - 财政年份:2019
- 资助金额:
$ 34.54万 - 项目类别:
PQ#12; Targeting Nampt-mediated NAD+ metabolism in chemobrain
质子Q
- 批准号:
9814276 - 财政年份:2019
- 资助金额:
$ 34.54万 - 项目类别:
Role of BubR1 as a juvenile protective factor in hippocampal aging
BubR1作为幼年保护因子在海马衰老中的作用
- 批准号:
10092880 - 财政年份:2018
- 资助金额:
$ 34.54万 - 项目类别:
Role of BubR1 as a juvenile protective factor in hippocampal aging
BubR1作为幼年保护因子在海马衰老中的作用
- 批准号:
9898040 - 财政年份:2018
- 资助金额:
$ 34.54万 - 项目类别:
相似海外基金
Co-designing a lifestyle, stop-vaping intervention for ex-smoking, adult vapers (CLOVER study)
为戒烟的成年电子烟使用者共同设计生活方式、戒烟干预措施(CLOVER 研究)
- 批准号:
MR/Z503605/1 - 财政年份:2024
- 资助金额:
$ 34.54万 - 项目类别:
Research Grant
Early Life Antecedents Predicting Adult Daily Affective Reactivity to Stress
早期生活经历预测成人对压力的日常情感反应
- 批准号:
2336167 - 财政年份:2024
- 资助金额:
$ 34.54万 - 项目类别:
Standard Grant
RAPID: Affective Mechanisms of Adjustment in Diverse Emerging Adult Student Communities Before, During, and Beyond the COVID-19 Pandemic
RAPID:COVID-19 大流行之前、期间和之后不同新兴成人学生社区的情感调整机制
- 批准号:
2402691 - 财政年份:2024
- 资助金额:
$ 34.54万 - 项目类别:
Standard Grant
Elucidation of Adult Newt Cells Regulating the ZRS enhancer during Limb Regeneration
阐明成体蝾螈细胞在肢体再生过程中调节 ZRS 增强子
- 批准号:
24K12150 - 财政年份:2024
- 资助金额:
$ 34.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Migrant Youth and the Sociolegal Construction of Child and Adult Categories
流动青年与儿童和成人类别的社会法律建构
- 批准号:
2341428 - 财政年份:2024
- 资助金额:
$ 34.54万 - 项目类别:
Standard Grant
Understanding how platelets mediate new neuron formation in the adult brain
了解血小板如何介导成人大脑中新神经元的形成
- 批准号:
DE240100561 - 财政年份:2024
- 资助金额:
$ 34.54万 - 项目类别:
Discovery Early Career Researcher Award
Laboratory testing and development of a new adult ankle splint
新型成人踝关节夹板的实验室测试和开发
- 批准号:
10065645 - 财政年份:2023
- 资助金额:
$ 34.54万 - 项目类别:
Collaborative R&D
Usefulness of a question prompt sheet for onco-fertility in adolescent and young adult patients under 25 years old.
问题提示表对于 25 岁以下青少年和年轻成年患者的肿瘤生育力的有用性。
- 批准号:
23K09542 - 财政年份:2023
- 资助金额:
$ 34.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Identification of new specific molecules associated with right ventricular dysfunction in adult patients with congenital heart disease
鉴定与成年先天性心脏病患者右心室功能障碍相关的新特异性分子
- 批准号:
23K07552 - 财政年份:2023
- 资助金额:
$ 34.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Issue identifications and model developments in transitional care for patients with adult congenital heart disease.
成人先天性心脏病患者过渡护理的问题识别和模型开发。
- 批准号:
23K07559 - 财政年份:2023
- 资助金额:
$ 34.54万 - 项目类别:
Grant-in-Aid for Scientific Research (C)